Background illustration for clinical trials search

Paid Clinical Trials Worcester

Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery

for
Postoperative Pain, Anxiety Postoperative, Opioid Use
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04912531

Recruiting

Very Low Carbohydrate Diets and Glucagon Response in T1DM

for
Type1diabetes
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 18 - 40

Code: NCT04200391

Recruiting

Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

for
Prediabetes, Diabetes, High Cholesterol/Hyperlipidemia,
Location: Sommerville MA
Sponsor: Cambridge Health Alliance

Sex: All

Age: 18 - 60

Code: NCT06988462

Recruiting

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Boston MA, New Haven CT, Commack NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06484062

Phase1, Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

for
Melanoma, Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, Richmond VA
Sponsor: IO Biotech

Sex: All

Age: 18+

Code: NCT05280314

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

for
Pulmonary Invasive Fungal Infections,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 21

Code: NCT03827694

Recruiting

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

for
Acute Leukemia
Location: Boston MA, Providence RI, The Bronx NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2+

Code: NCT04811560

Phase1, Phase2, Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase2, Recruiting

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

for
Advanced Hodgkin Lymphoma, Classic Hodgkin Lymphoma,
Location: Boston MA, New York NY, St Louis MO, Seattle WA,
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06745076

Phase2, Recruiting

Product Surveillance Registry

for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Holyoke MA, Hartford CT, New Haven CT,
Sponsor: Medtronic

Sex: All

Age: 0+

Code: NCT01524276

Recruiting

Avo In R/R And Previously Untreated MCL

for
Mantle Cell Lymphoma, Refractory Lymphoma
Location: Boston MA, Chicago IL
Sponsor: Austin I Kim

Sex: All

Age: 18+

Code: NCT04855695

Phase1, Phase2, Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Boston MA, Shirley NY, Lake Success NY, New York NY,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase1, Phase2, Recruiting

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

for
Myeloid Leukemia, Philadelphia Positive
Location: Boston MA, New York NY, Philadelphia PA, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1 - 17

Code: NCT04925479

Phase1, Phase2, Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

for
T-Cell Lymphoma
Location: Boston MA, New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05313243

Phase2, Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT04792489

Phase2, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, Hackensack NJ, New York NY, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase1, Recruiting

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

for
Mesothelioma
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03683680

Recruiting

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, Fairfax VA, Grand Rapids MI, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06797336

Phase1, Recruiting

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

for
Brain Metastases
Location: Boston MA, Wilkes-Barre PA, Syracuse NY, Montreal,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03550391

Phase3, Recruiting

Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy.

for
Brain Metastases, Solid Tumors
Location: Boston MA, New York city NY, Pittsburgh PA
Sponsor: Aposense Ltd.

Sex: All

Age: 18+

Code: NCT00805636

Phase2, Recruiting